id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2375-0003,FDA,FDA-2022-N-2375,Authorization of Emergency Use of an In Vitro Diagnostic Device in Response to an Outbreak of Mpox; Availability,Notice,Announcement,2022-12-30T05:00:00Z,2022,12,2022-12-30T05:00:00Z,,2022-12-30T16:46:00Z,2022-28460,0,0,0900006485564bf9
FDA-2022-N-2375-0002,FDA,FDA-2022-N-2375,Authorization of Emergency Use of an In Vitro Diagnostic Device for Detection of Monkeypox Virus; Availability,Notice,Announcement,2022-10-27T04:00:00Z,2022,10,2022-10-27T04:00:00Z,,2022-10-27T14:17:49Z,2022-23391,0,0,0900006485462671
FDA-2022-N-2375-0001,FDA,FDA-2022-N-2375,Authorization of Emergency Use of an In Vitro Diagnostic Device for Detection of Monkeypox Virus; Availability,Notice,Announcement,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T17:01:37Z,2022-21829,0,0,09000064853d45a0